Aldevron

The energy carried through earlier today at ICGT in Paris, where our joint ALD / IDT / Cytiva workshop—Accelerating Personalized CRISPR Therapies—brought together strong engagement around what it takes to advance these programs from concept to clinic.

Great to see the collaboration across teams and hear how others in the field are tackling challenges around speed, control, and scalability in personalized approaches. Sessions like this continue to reinforce how important integrated expertise is as expectations for performance and precision evolve.

If you’re attending ICGT, there’s still time to connect onsite.

Clinical trials are foundational to advancing new therapies and improving patient care.

On International Clinical Trials Day, we recognize the researchers, clinicians, and participants whose commitment helps translate scientific discovery into meaningful health outcomes.

The 14th Galenus Workshop is underway, bringing together experts focused on advancing mRNA science and delivery.

Work across process optimization, quality, and scalability continues to push the field forward as expectations for performance and precision grow.

Tomorrow, our very own Nicolò Sacchetti will present a poster titled:
“Impact of dsRNA on cellular viability and reduction of dsRNA in in vitro transcribed mRNA via enzymatic optimization and polishing.”

May 19 | 12:30–12:45

If you’re attending, this is an opportunity to explore how dsRNA mitigation strategies can influence mRNA quality and downstream outcomes.